| Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ? | Open forum infectious diseases |  | | 2024 | 49 | 14 |
|
| The future of beta cells replacement in the era of regenerative medicine and organ bioengineering | Transplant international | | | 2024 | 43 | 19 |
|
| Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients | Transplant international | | | 2024 | 52 | 17 |
|
| Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release | Diabetes |  | | 2024 | 225 | 1 |
|
| Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The journal of infectious diseases | | | 2024 | 32 | 2 |
|
| Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | | | 2024 | 38 | 10 |
|
| Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter study | Bone marrow transplantation | | | 2024 | 30 | 7 |
|
| Vaccine-preventable infections among solid organ transplant recipients in Switzerland | JAMA network open | | | 2023 | 69 | 11 |
|
| Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | | | 2023 | 27 | 8 |
|
| Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | | | 2023 | 13 | 7 |
|
| Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial | Clinical infectious diseases | | | 2023 | 72 | 21 |
|
| Intercellular contacts affect secretion and biosynthesis of pancreatic islet cells | Journal of endocrinology | | | 2023 | 36 | 27 |
|
| Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | | | 2023 | 18 | 10 |
|
| Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological Update | Open forum infectious diseases | | | 2023 | 70 | 17 |
|
| Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | | | 2023 | 20 | 9 |
|
| The relevance of advanced therapy medicinal products in the field of transplantation and the need for academic research access : overcoming bottlenecks and claiming a new time | Transplant international | | | 2023 | 25 | 5 |
|
| Generation of Insulin-Producing Multicellular Organoids | Methods in molecular biology | | | 2023 | 283 | 11 |
|
| The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study | Frontiers in immunology | | | 2022 | 112 | 28 |
|
| A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation | Transplant international | | | 2022 | 91 | 73 |
|
| A National Survey Comparing Patients' and Transplant Professionals' Research Priorities in the Swiss Transplant Cohort Study | Transplant international | | | 2022 | 85 | 51 |
|
| From islet of Langerhans transplantation to the bioartificial pancreas | La Presse médicale | | | 2022 | 167 | 80 |
|
| Bio-Engineering of Pre-Vascularized Islet Organoids for the Treatment of Type 1 Diabetes | Transplant international | | | 2022 | 372 | 149 |
|
| Organoids: a systematic review of ethical issues | Stem cell research & therapy | | | 2022 | 23 | 18 |
|
| Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients | BMC infectious diseases | | | 2022 | 81 | 45 |
|
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | | | 2022 | 153 | 45 |
|
| Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial | Clinical infectious diseases | | | 2022 | 72 | 15 |
|
| An inhibitor-mediated beta-cell dedifferentiation model reveals distinct roles for FoxO1 in glucagon repression and insulin maturation | Molecular metabolism | | | 2021 | 307 | 139 |
|
| 402.7: Homemade hydrogel from human amniotic membrane improves islet transplantation outcomes in diabetic immunodeficient mice | Transplantation | | | 2021 | 170 | 2 |
|
| Mini-organs forum: how to advance organoid technology to organ transplant community | Transplant international | | | 2021 | 166 | 0 |
|
| P.169: Decellularized cotyledons isolated from human placenta used like a scaffold for the generation of a human bioartificial pancreas | Transplantation | | | 2021 | 131 | 1 |
|
| Failure mode and effect analysis in human islet isolation: from the theoretical to the practical risk | Islets | | | 2021 | 154 | 0 |
|
| Mechanisms of Immunomodulation and Cytoprotection Conferred to Pancreatic Islet by Human Amniotic Epithelial Cells | Stem cell reviews and reports | | | 2021 | 209 | 112 |
|
| Bioengineered Islet Cell Transplantation | Current transplantation reports | | | 2021 | 297 | 81 |
|
| The Role and Clinical Interest of Extracellular Vesicles in Pregnancy and Ovarian Cancer | Biomedicines | | | 2021 | 156 | 55 |
|
| Impact of ischemia time on islet isolation success and posttransplantation outcomes: A retrospective study of 452 pancreas isolations | American journal of transplantation | | | 2021 | 190 | 0 |
|
| Biosynthetic activity differs between islet cell types and in beta cells is modulated by glucose and not by secretion | Endocrinology | | | 2021 | 240 | 79 |
|
| 402.5: Human Amniotic Epithelial Cells Immunomodulatory Properties Protect Islets Against Inflammatory Cytokines In Vitro | Transplantation | | | 2021 | 151 | 1 |
|
| Pancréatectomie totale et autotransplantation d'îlots : état actuel et nouvelles perspectives, | Revue médicale suisse | | | 2021 | 301 | 3 |
|
| Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy | Stem Cell Reviews and Reports | | | 2021 | 418 | 198 |
|
| Immunomodulatory Properties of Amniotic Membrane Derivatives and Their Potential in Regenerative Medicine | Current Diabetes Reports | | | 2020 | 840 | 108 |
|
| Organoïdes sécréteurs d'insuline: Des "super-îlots" comme premier pas vers le pancréas bioartificiel | Médecine/Sciences | | | 2020 | 266 | 676 |
|
| I’ve got you under my skin | Nature metabolism | | | 2020 | 27 | 42 |
|
| Generation of insulin-secreting organoids: a step toward engineering and transplanting the bioartificial pancreas | Transplant International | | | 2020 | 259 | 129 |
|
| Engineering of primary pancreatic islet cell spheroids for three-dimensional culture or transplantation: a methodological comparative study | Cell Transplantation | | | 2020 | 335 | 170 |
|
| NLRP3 inflammasome is activated in rat pancreatic islets by transplantation and hypoxia | Scientific Reports | | | 2020 | 258 | 112 |
|
| Shielding islets with human amniotic epithelial cells enhances islet engraftment and revascularization in a murine diabetes model | American Journal of Transplantation | | | 2020 | 249 | 151 |
|
| Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes | Nature Communications | | | 2019 | 345 | 223 |
|
| Macrophage migration inhibitory factor regulates TLR4 expression and modulates TCR/CD3-mediated activation in CD4+ T lymphocytes | Scientific Reports | | | 2019 | 365 | 184 |
|
| Decellularized human placenta supports hepatic tissue and allows rescue in acute liver failure | Hepatology | | | 2018 | 244 | 318 |
|
| NLRP3 inflammasome is expressed and regulated in human islets | Cell Death & Disease | | | 2018 | 451 | 183 |
|
| Regenerative medicine and diabetes: targeting the extracellular matrix beyond the stem cell approach and encapsulation technology | Frontiers in Endocrinology | | | 2018 | 319 | 142 |
|
| Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity | Cell | | | 2017 | 286 | 185 |
|
| Loss of end-differentiated beta-cell phenotype following pancreatic islet transplantation | American Journal of Transplantation | | | 2017 | 418 | 214 |
|
| The Role of Inflammation in β-cell Dedifferentiation | Scientific Reports | | | 2017 | 255 | 141 |
|
| Advances in pancreatic islet monolayer culture on glass surfaces enable super-resolution microscopy and insights into beta cell ciliogenesis and proliferation | Scientific Reports | | | 2017 | 197 | 209 |
|
| Prevention of age-induced N(ε)-(carboxymethyl)lysine accumulation in the microvasculature | European Journal of Clinical Investigation | | | 2016 | 251 | 0 |
|
| Single-cell transcriptomes reveal characteristic features of human pancreatic islet cell types | EMBO Reports | | | 2016 | 242 | 196 |
|
| Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose | Cell Metabolism | | | 2016 | 448 | 179 |
|
| Asymmetrical distribution of δ and PP cells in human pancreatic islets | Journal of Endocrinology | | | 2016 | 496 | 0 |
|
| Beta-Cell Replacement: Pancreas and Islet Cell Transplantation | Novelties in Diabetes | | | 2016 | 218 | 0 |
|
| Toward Clinical Application of the Bioartificial Pancreas | Transplantation | | | 2015 | 591 | 241 |
|
| Ischemic preconditioning affects long-term cell fate through DNA damage-related molecular signaling and altered proliferation | The American Journal of Pathology | | | 2014 | 179 | 130 |
|
| Correction of diabetes mellitus by transplanting minimal mass of syngeneic islets into vascularized small intestinal segment | American Journal of Transplantation | | | 2013 | 229 | 0 |
|
| An isolated venous sac as a novel site for cell therapy in diabetes mellitus | Transplantation | | | 2012 | 213 | 0 |
|
| Long-term engraftment and function of transplanted pancreatic islets in vascularized segments of small intestine | Transplant International | | | 2011 | 234 | 176 |
|
| Perturbations in ataxia telangiectasia mutant signaling pathways after drug-induced acute liver failure and their reversal during rescue of animals by cell therapy | The American Journal of Pathology | | | 2011 | 213 | 103 |
|
| Hepatocyte transplantation and drug-induced perturbations in liver cell compartments | Hepatology | | | 2008 | 226 | 0 |
|
| Stage-specific regulation of adhesion molecule expression segregates epithelial stem/progenitor cells in fetal and adult human livers | Hepatology International | | | 2008 | 218 | 119 |
|
| Monocrotaline promotes transplanted cell engraftment and advances liver repopulation in rats via liver conditioning | Hepatology | | | 2006 | 210 | 0 |
|
| Isolated small intestinal segments support auxiliary livers with maintenance of hepatic functions | Nature Medicine | | | 2004 | 238 | 0 |
|
| Heterotopic auxiliary liver in an isolated and vascularized segment of the small intestine in rats | Transplantation | | | 2003 | 235 | 0 |
|
